These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 1809589)
1. Intermittent corticosteroid maintenance treatment of psoriasis: a double-blind multicenter trial of augmented betamethasone dipropionate ointment in a pulse dose treatment regimen. Katz HI; Prawer SE; Medansky RS; Krueger GG; Mooney JJ; Jones ML; Samson CR Dermatologica; 1991; 183(4):269-74. PubMed ID: 1809589 [TBL] [Abstract][Full Text] [Related]
2. Calcitriol shows greater persistence of treatment effect than betamethasone dipropionate in topical psoriasis therapy. Camarasa JM; Ortonne JP; Dubertret L J Dermatolog Treat; 2003 Jan; 14(1):8-13. PubMed ID: 12745849 [TBL] [Abstract][Full Text] [Related]
3. A double-blind, multicenter comparison between 0.05% halobetasol propionate ointment and 0.05% betamethasone dipropionate ointment in chronic plaque psoriasis. Mensing H; Korsukewitz G; Yawalkar S J Am Acad Dermatol; 1991 Dec; 25(6 Pt 2):1149-52. PubMed ID: 1757606 [TBL] [Abstract][Full Text] [Related]
4. Betamethasone dipropionate in optimized vehicle. Intermittent pulse dosing for extended maintenance treatment of psoriasis. Katz HI; Hien NT; Prawer SE; Scott JC; Grivna EM Arch Dermatol; 1987 Oct; 123(10):1308-11. PubMed ID: 3662562 [TBL] [Abstract][Full Text] [Related]
5. Comparison of fluticasone propionate ointment, 0.005%, and betamethasone-17,21-dipropionate ointment, 0.05%, in the treatment of psoriasis. Roberts DT Cutis; 1996 Feb; 57(2 Suppl):27-31. PubMed ID: 8646866 [TBL] [Abstract][Full Text] [Related]
7. Efficacy of once-daily treatment regimens with calcipotriol/betamethasone dipropionate ointment and calcipotriol ointment in psoriasis vulgaris. Kragballe K; Noerrelund KL; Lui H; Ortonne JP; Wozel G; Uurasmaa T; Fleming C; Estebaranz JL; Hanssen LI; Persson LM Br J Dermatol; 2004 Jun; 150(6):1167-73. PubMed ID: 15214905 [TBL] [Abstract][Full Text] [Related]
8. Topical calcipotriene 0.005% and betamethasone dipropionate 0.064% maintains efficacy of etanercept after step-down dose in patients with moderate-to-severe plaque psoriasis: results of an open label trial. Kircik LH J Drugs Dermatol; 2011 Aug; 10(8):878-82. PubMed ID: 21818509 [TBL] [Abstract][Full Text] [Related]
9. A comparison of clobetasol propionate 0.05 percent ointment and an optimized betamethasone dipropionate 0.05 percent ointment in the treatment of psoriasis. Jacobson C; Cornell RC; Savin RC Cutis; 1986 Mar; 37(3):213-4, 216, 218-20. PubMed ID: 3514155 [TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of a new combination of calcipotriol and betamethasone dipropionate (once or twice daily) compared to calcipotriol (twice daily) in the treatment of psoriasis vulgaris: a randomized, double-blind, vehicle-controlled clinical trial. Guenther L; Van de Kerkhof PC; Snellman E; Kragballe K; Chu AC; Tegner E; Garcia-Diez A; Springborg J Br J Dermatol; 2002 Aug; 147(2):316-23. PubMed ID: 12174105 [TBL] [Abstract][Full Text] [Related]
11. A new calcipotriol/betamethasone dipropionate formulation (Daivobet) is an effective once-daily treatment for psoriasis vulgaris. Kaufmann R; Bibby AJ; Bissonnette R; Cambazard F; Chu AC; Decroix J; Douglas WS; Lowson D; Mascaro JM; Murphy GM; Stymne B Dermatology; 2002; 205(4):389-93. PubMed ID: 12444337 [TBL] [Abstract][Full Text] [Related]
12. Spotlight on calcipotriene/betamethasone dipropionate in psoriasis vulgaris of the trunk, limbs, and scalp. McCormack PL Am J Clin Dermatol; 2011 Dec; 12(6):421-4. PubMed ID: 21967117 [TBL] [Abstract][Full Text] [Related]
13. Efficacy, safety, and cost-effectiveness of all-trans retinoic acid/Clobetasol Propionate Compound Ointment in the treatment of mild to moderate psoriasis vulgaris: A randomized, single-blind, multicenter clinical trial. Xia L; Li R; Wang Y; Lin Z; Zheng J; Li X; Lu Q; Zhang J; Jin H; Fu L; Zhang X; Liu Y; Yang S; Xiao F; Gao XH Dermatol Ther; 2018 Sep; 31(5):e12632. PubMed ID: 30253049 [TBL] [Abstract][Full Text] [Related]
14. A new calcipotriol/betamethasone formulation with rapid onset of action was superior to monotherapy with betamethasone dipropionate or calcipotriol in psoriasis vulgaris. Douglas WS; Poulin Y; Decroix J; Ortonne JP; Mrowietz U; Gulliver W; Krogstad AL; Larsen FG; Iglesias L; Buckley C; Bibby AJ Acta Derm Venereol; 2002; 82(2):131-5. PubMed ID: 12125943 [TBL] [Abstract][Full Text] [Related]
15. Once-daily treatment of psoriasis with topical glucocorticosteroid ointments. Lane AT; Wachs GN; Weston WL J Am Acad Dermatol; 1983 Apr; 8(4):523-5. PubMed ID: 6853785 [TBL] [Abstract][Full Text] [Related]
16. Intermittent topical treatment of psoriasis with betamethasone dipropionate 0.05 percent cream. van Dijk E; Bakkers EJ; Go MJ; Montnor LP; Roessel FE; van der Wateren AR; Wuite J Cutis; 1983 Sep; 32(3):284-5, 287. PubMed ID: 6354613 [TBL] [Abstract][Full Text] [Related]
17. Comparison of diflorasone diacetate and betamethasone dipropionate ointment in the treatment of psoriasis. Leibsohn E J Int Med Res; 1982; 10(1):22-7. PubMed ID: 7073809 [TBL] [Abstract][Full Text] [Related]
18. Treatment of psoriasis vulgaris with the two-compound product calcipotriol/betamethasone dipropionate followed by different formulations of calcipotriol. Cassano N; Miracapillo A; Coviello C; Loconsole F; Bellino M; Vena GA Clin Drug Investig; 2006; 26(4):227-33. PubMed ID: 17163256 [TBL] [Abstract][Full Text] [Related]
19. Calcipotriol ointment in nail psoriasis: a controlled double-blind comparison with betamethasone dipropionate and salicylic acid. Tosti A; Piraccini BM; Cameli N; Kokely F; Plozzer C; Cannata GE; Benelli C Br J Dermatol; 1998 Oct; 139(4):655-9. PubMed ID: 9892909 [TBL] [Abstract][Full Text] [Related]
20. Amcinonide vs. betamethasone dipropionate ointments in the treatment of psoriasis. Huntley AC; Isseroff R Cutis; 1985 May; 35(5):489-92. PubMed ID: 3891239 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]